Krishnamurthi Ganapathi obtained his DSc degree from the University of Madras in 1941. His specialization was organic chemistry, synthetic drugs, antibiotics, biochemistry and fermentation technology. His notable contributions were the manufacturing process of sulphathiazole; synthesis of potential antimalarials and the production of paludrine; the biosynthetic pathway for penicillin production by the mould; biochemistry of Penicillium chrysogenum and some pathogenic bacteria. Dr. Ganapathi was responsible for building the Chemotherapy Department at Haffkine Institute, Mumbai and supported in setting up the Research laboratory of the Hindustan Antibiotics, Pune. He was the recipient of Sudborough Medal of Indian Institute of Science, Bangalore; Fellow of Indian Academy of Sciences and Chemical Society of UK.

Bhuban Mohan Gupta obtained his PhD from the University of Pittsburgh, USA in 1950. Specialized in Virology, he isolated an antiviral agent (Double Stranded RNA) with capacity to induce interferon (pH-labile and pH-stable) and modulate immune responses in vertebrates. His research led to the discovery of a new bacteriophage called CVX-5. His study of the plaque formation of CVX-5 using the host E-coli was used to understand and analyze mammalian cell-virus interaction. Dr. Gupta was the Assistant Director, Central Drug Research Institute, Lucknow. He was a member of the Association of Microbiologists. Dr. Gupta was conferred with Indian Chemical Manufacturers Association Lecture in 1971 and Vyas Memorial Award Lecture in 1978.